SCYNEXIS, Inc. - Common Stock —— 现金流量表 (NASDAQ:SCYX) | MetaTrader

展开完整图表完整图表

Financials

概览声明统计

每季度年度

经营活动产生的现金 -49.35 M-54.56 M-79.88 M60.16 M-24.01 M-5.28 M -5.92 M 投资活动产生的现金 6.47 M-1.17 M-27.39 M-34.88 M6.15 M24.31 M 11.34 M 融资活动产生的现金 94 M67.12 M48.6 M-36.72 M-139 K-14.17 M 23.95 M 自由现金流 -49.35 M-54.56 M-79.88 M60.16 M-24.01 M-5.28 M -5.92 M

新闻

Stock Market Today: S&P 500, Dow Jones Futures Gain Despite US 'Defensive Strikes' On Iran—Elbit Systems

SCYNEXIS, Inc. (SCYX) Discusses Transformative Asset Acquisition and Strategic Shift Toward ADPKD Therapeutics - Slideshow (NASDAQ:SCYX) 2026-04-01

Brookline Capital下调SCYNEXIS目标价，基于估值考量

Brookline Capital cuts SCYNEXIS stock price target on valuation

SCYNEXIsQ1每股收益及营收超出预期

Scynexis Inc earnings beat by $0.12, revenue topped estimates

SCYNEXIS在SCY-247静脉注射制剂试验中完成首批患者给药

SCYNEXIS doses first patients in SCY-247 IV formulation trial

JERSEY CITY - FDA grants fast track and QIDP designations to SCYNEXIS drug

Scynexis获得纳斯达克180天延期以满足上市要求

Scynexis receives 180-day extension from Nasdaq to meet listing requirements

SCYNEXIS获得700万美元年度拨款用于抗真菌研究